Across TCGA pan-cancer cohorts, RNU2-37P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNU2-37P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU2-37P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU2-37P is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.

BRCA, CHOL, and THCA are the cancer types where RNU2-37P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU2-37P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	IV	−0.540	.001	4	view →
CHOL	All	II,III,IV	+0.495	<.001	2	view →
THCA	All	All	−0.101	.004	2	view →
LUAD	All	III,IV	−0.191	.044	1	view →
KICH	All	All	−0.100	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RNU2-37P RNA expression & survival · all RNU2-37P data types